Trials / Unknown
UnknownNCT05416177
Assessment of Vivity With French Clinical Data Related to the Toric Model Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 31 (estimated)
- Sponsor
- Versailles Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Presbyopia-correcting implant (PC-IOL): AcrySof IQ Vivity (Alcon) has been evaluated in 2 large pivotal trials (US and OUS trials). These tests showed that this PC-IOL restored intermediate visual acuity (IVA) and near visual acuity (NV A) superior to that of the reference monofocal AcrySof implant. In these tests, it was demonstrated that distance visual acuity (DVA) was non-inferior. However, the intermediate visual acuity for this implant in its toric version has not been evaluated.
Conditions
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-04-01
- Completion
- 2023-07-01
- First posted
- 2022-06-13
- Last updated
- 2022-08-25
Source: ClinicalTrials.gov record NCT05416177. Inclusion in this directory is not an endorsement.